After PFKFB3 KO in ESCC cells, AGPG CRISPR KO had mild effects on aerobic glycolysis and cell proliferation (Supplementary Fig. 5a, b). This evidence concerns the gene PFKFB3 and esophageal squamous cell carcinoma.